GILUPI is a medical diagnostics company with an initial focus on the prenatal and cancer market. The company is developing an innovative new diagnostic product based on nanotechnology. Our goal is to catch specific cells, which can be found only in very low concentration in the blood. The first application for our new nanosensor device will be prenatal diagnoses of chromosomal aberration out of maternal blood. The second application will focus on the early diagnosis of cancer.
Am Mühlenberg 11
14476 Potsdam OT Golm
Telephone | +49 (0)331.58184782
Fax | +49 (0)331.58184780
Link | http://www.gilupi.com/